Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies

Abstract Background During the initial wave of the COVID-19 pandemic, there was a surprisingly low incidence of SARS-CoV-2 among People Who Use Drugs (PWUD) in Oslo, Norway, despite their heightened vulnerability regarding risk of infection and severe courses of the disease.This study aims to invest...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Harm Reduction Journal
المؤلفون الرئيسيون:	Linda Elise Couëssurel Wüsthoff, Fridtjof Lund-Johansen, Kathleen Henriksen, Gull Wildendahl, Jon-Aksel Jacobsen, Leni Gomes, Hina Sarwar Anjum, Regine Barlinn, Anne-Marte Bakken Kran, Ludvig Andre Munthe, John T. Vaage
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	BMC 2024-06-01
الموضوعات:	SARS-CoV-2 COVID-19 Substance use disorders Seroprevalence Antibody response Corona vaccine
الوصول للمادة أونلاين:	https://doi.org/10.1186/s12954-024-01023-9